Business Description
Innova Captab Ltd
ISIN : INE0DUT01020
Total Employee Number:
2,298Compare
Compare
Traded in other countries / regions
INNOVACAP.India IPO Date
2023-12-29Description
Innova Captab Ltd is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company has identified "Drugs and pharmaceutical products" as single operating segment. The company has presence in India, and Outside India. The company generates majority of revenue from India. The company's products are Cephalosporins, Proton Pump Inhibitor, Antocholinergic and Heparin NSAIDs, Analgesics and Antipyretic, Anticold and Antiallergic, Antiemetic, Antidiabetic, Antispasmodic, Antifibrinolytic, Cardiovascular, Antioxidant and Vitamins, Antihyperuricemia and Antigout, Fluoroquinolone and Macrolide, Nootropics and Neurotonics/ Neurotrophics, Antiulcerative, Antimalarial Anxiolytic, Anticonvulsant and Antipsychotic, Bladder and Prostate Disorder, etc.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.32 | |||||
Debt-to-EBITDA | 1.37 | |||||
Interest Coverage | 11.44 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 6.35 | |||||
Beneish M-Score | -1.99 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.1 | |||||
3-Year EBITDA Growth Rate | 27.1 | |||||
3-Year EPS without NRI Growth Rate | 27.9 | |||||
3-Year Book Growth Rate | 58 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 56.56 | |||||
9-Day RSI | 52.99 | |||||
14-Day RSI | 53.97 | |||||
3-1 Month Momentum % | 30.12 | |||||
6-1 Month Momentum % | 40.83 | |||||
12-1 Month Momentum % | 7.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.87 | |||||
Quick Ratio | 1.29 | |||||
Cash Ratio | 0.09 | |||||
Days Inventory | 84.03 | |||||
Days Sales Outstanding | 86.87 | |||||
Days Payable | 90.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.21 | |||||
Dividend Payout Ratio | 0.08 | |||||
Forward Dividend Yield % | 0.41 | |||||
5-Year Yield-on-Cost % | 0.21 | |||||
Shareholder Yield % | -0.53 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 35.41 | |||||
Operating Margin % | 11.86 | |||||
Net Margin % | 8.65 | |||||
EBITDA Margin % | 15.36 | |||||
FCF Margin % | 2.95 | |||||
OCF Margin % | 7.15 | |||||
ROE % | 13.76 | |||||
ROA % | 8.27 | |||||
ROIC % | 10.71 | |||||
3-Year ROIIC % | 6.78 | |||||
ROC (Joel Greenblatt) % | 16.62 | |||||
ROCE % | 15.99 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 39.97 | |||||
Forward PE Ratio | 28.43 | |||||
PE Ratio without NRI | 39.97 | |||||
Price-to-Owner-Earnings | 59.14 | |||||
PEG Ratio | 1.2 | |||||
PS Ratio | 3.46 | |||||
PB Ratio | 5.18 | |||||
Price-to-Tangible-Book | 5.24 | |||||
Price-to-Free-Cash-Flow | 116.95 | |||||
Price-to-Operating-Cash-Flow | 48.34 | |||||
EV-to-EBIT | 28.64 | |||||
EV-to-EBITDA | 23.47 | |||||
EV-to-Revenue | 3.6 | |||||
EV-to-FCF | 119.14 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.61 | |||||
Price-to-Graham-Number | 3.05 | |||||
| Price-to-Net-Current-Asset-Value | 31.85 | |||||
Earnings Yield (Greenblatt) % | 3.5 | |||||
FCF Yield % | 0.87 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Innova Captab Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 16,300.18 | ||
| EPS (TTM) (₹) | 24.62 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 28.1 | ||
| 14-Day RSI | 53.97 | ||
| 14-Day ATR (₹) | 29.310477 | ||
| 20-Day SMA (₹) | 975.7 | ||
| 12-1 Month Momentum % | 7.47 | ||
| 52-Week Range (₹) | 608.25 - 1033 | ||
| Shares Outstanding (Mil) | 57.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Innova Captab Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Innova Captab Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 2.000000 Cash Dividend | 2026-01-30 | 677.00 (-2.64%) |
Show
Entries
Innova Captab Ltd Frequently Asked Questions
What is Innova Captab Ltd(BOM:544067)'s stock price today?
The current price of BOM:544067 is ₹974.75. The 52 week high of BOM:544067 is ₹1033.00 and 52 week low is ₹608.25.
When is next earnings date of Innova Captab Ltd(BOM:544067)?
The next earnings date of Innova Captab Ltd(BOM:544067) is .
Does Innova Captab Ltd(BOM:544067) pay dividends? If so, how much?
The Dividend Yield %  of Innova Captab Ltd(BOM:544067) is 0.21% (As of Today), Highest Dividend Payout Ratio of Innova Captab Ltd(BOM:544067) was 0.08. The lowest was 0.08. And the median was 0.08. The  Forward Dividend Yield % of Innova Captab Ltd(BOM:544067) is 0.41%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Innova Captab Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers